Live Breaking News & Updates on Pipeline appears robust

Emerging From the Pandemic: CDRH In-Person Meeting Status and Premarket Workload

CDRH is pleased to announce that we have been operating under normal review timelines for all incoming premarket submissions for almost a year, and we’re accepting all submission types for review.

Jeff-shuren , William-maisel , Drug-administration-center , Office-of-product-evaluation , Radiological-health , Product-evaluation , Drug-administration , Premarket-workload , Use-authorization , Premarket-submission , Pipeline-appears-robust ,